Trials / Completed
CompletedNCT04640285
Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by Smokers
A Randomized, Open-Label, Single-Center, Cross-Over Study of Adult Smokers to Assess Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With RELX Infinity Electronic Nicotine Delivery Systems (ENDS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Cheerain HK Limited · Industry
- Sex
- All
- Age
- 22 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate nicotine uptake and exposure, the abuse liability, and puffing topography associated with the use of an electronic nicotine delivery system ENDS with tobacco- and menthol-flavored e-liquids in current smokers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RELX ENDS Tobacco Flavor | Ad libitum use of RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions |
| OTHER | RELX ENDS Menthol Flavor | Ad libitum use of RELX ENDS Menthol flavor product during 8-hour and 5-minute use sessions |
| OTHER | Usual Brand Cigarette | Ad libitum use of subjects usual brand product during 8-hour and single cigarette use sessions |
| OTHER | Nicorette White Ice Mint nicotine polacrilex gum | Ad libitum use of Nicorette White Ice Mint nicotine polacrilex gum product during 8-hour and 30-minute use sessions |
Timeline
- Start date
- 2020-11-03
- Primary completion
- 2021-03-12
- Completion
- 2021-03-19
- First posted
- 2020-11-23
- Last updated
- 2021-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04640285. Inclusion in this directory is not an endorsement.